Kategorien
-
Adhesives
5
Amines
94
Amino Acids
182
Analytical Reagents
682
Antibiotics
253
Bioactive Small Molecules
726
Aroma Chemicals
209
Biochemicals
1017
Boronic Acids
4
Buffers
98
Building Blocks
1796
Carbohydrates
176
Catalysts
100
Chiral Compounds
54
Detergents
59
Diagnostic Raw Materials
253
Flavours and Fragrance Materials
208
Fluorinated Products
43
Furans
5
Gases in Solution
50
Grignard Reagents
23
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
327
Ion-Pair Reagents
24
Ligands
80
Organics
1318
Oxazoles
3
Peptide Reagents
89
Phenols
45
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
756
Salts
286
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
294
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
238
Water Analysis
12
Lithium metaborate
(25620798 | 13453-69-5)
| CAS: | 13453-69-5 |
|---|---|
| Molekularformel: | LiBO2 |
| Molekulargewicht: | 49.75 |
| Verfügbarkeit: | Auf Lager |
|---|---|
| Downloads: | | |
| 25620798-25g | 25g | £31.10 | |
| Bulk Menge | |||
| 25620798-25g | 25g | €43.60 | |
| Bulk Menge | |||
| 25620798-25g | 25g | $46.70 | |
| Bulk Menge | |||
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
| Product Code | 25620798 | ||||
| Product Name | Lithium metaborate | ||||
| Categories | Analytical Reagents Building Blocks Inorganic Chemicals Salts | ||||
| CAS | 13453-69-5 | ||||
| Molecular Formula | LiBO2 | ||||
| Molecular Weight | 49.75 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 2840209090 |
Produktspezifikation
| Chloride (Cl) | ≤0.005% | ||||
| Solubility | 2% solution in boiling water is colourless | ||||
| Assay | ≥99.00% | ||||
| Appearance | White crystalline powder | ||||
| Iron (Fe) | ≤0.005% | ||||
| Sulphate (SO4) | ≤0.005% | ||||
| Calcium (Ca) | ≤0.005% | ||||
| Loss on ignition (800 Deg C) | ≤1.0% | ||||
| Sodium (Na) | ≤0.005% |
Sicherheitsinformation
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|